Citation: | WANG Ran, CUI Guoli, LI Yajiang. Values of serum endothelial cell specific molecule-1 and visceral adipose tissue-derived serine protease inhibitor levels in the diagnosis of type 2 diabetic macroangiopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 103-106. DOI: 10.7619/jcmp.20201470 |
[1] |
李丽疆, 郭三敏, 孙健, 等. 非对称二甲基精氨酸、血管内皮生长因子与2型糖尿病合并大血管病变的相关性研究[J]. 中国糖尿病杂志, 2019, 27(1): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGTL201901010.htm
|
[2] |
ZHONG C, YANG X, FENG Y, et al. Trained immunity: an underlying driver of inflammatory atherosclerosis[J]. Front Immunol, 2020, 11: 284. doi: 10.3389/fimmu.2020.00284
|
[3] |
ÇIMEN T, EFE T H, AKYEL A, et al. Human endothelial cell-specific molecule-1 (endocan) and coronary artery disease and microvascular angina[J]. Angiology, 2016, 67(9): 846-853. doi: 10.1177/0003319715625827
|
[4] |
HUANG X, CHEN C, WANG X, et al. Prognostic value of endocan expression in cancers: evidence from meta-analysis[J]. Oncotargets Ther, 2016, 9: 6297-6304. doi: 10.2147/OTT.S110295
|
[5] |
楚轶, 卢少平, 冯品, 等. 血清endocan质量浓度与急性心肌梗死的相关性研究[J]. 现代医学, 2015, 43(5): 588-591. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX201505015.htm
|
[6] |
KLESSENS C Q F, ZANDBERGEN M, WOLTERBEEK R, et al. Macrophages in diabetic nephropathy in patients with type 2 diabetes[J]. Nephrol Dial Transplant, 2017, 32(8): 1322-1329.
|
[7] |
EL-MESALLAMY H O, KASSEM D H, EL-DEMERDASH E, et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus[J]. Metabolism, 2011, 60(1): 63-70. doi: 10.1016/j.metabol.2010.04.008
|
[8] |
FENG R N, LI Y C, WANG C, et al. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis[J]. Diabetes Res Clin Pract, 2014, 106(1): 88-94. doi: 10.1016/j.diabres.2014.07.026
|
[9] |
VAN J A, SCHOLEY J W, KONVALINKA A. Insights into diabetic kidney disease using urinary proteomics and bioinformatics[J]. J Am Soc Nephrol, 2017, 28(4): 1050-1061. doi: 10.1681/ASN.2016091018
|
[10] |
SATHYASEELAN A J. Assessment of serum VASPIN levels among type 2 diabetes mellitus patients with or without acute coronary syndrome[J]. J CLINICAL DIAGNOSTIC RESEARCH, 2016, 10(12): BC07-BC10. http://europepmc.org/abstract/MED/28208842
|
[11] |
YANG W, LI Y, TIAN T, et al. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications[J]. BMC Endocr Disord, 2017, 17(1): 67-69. doi: 10.1186/s12902-017-0216-0
|
[12] |
吕英俊, 余平, 陈奕, 等. 冠状动脉粥样硬化性心脏病患者血清adropin蛋白与炎性指标水平变化及相关性分析[J]. 重庆医学, 2019, 48(23): 4116-4118. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYY201805021.htm
|